药学研究2016，Vol.35Issue(12)：734-736,3.DOI:10.13506/j.cnki.jpr.2016.12.015
羟乙基淀粉系列原料药质量控制研究
Discussion on the controI of hydroxyethyI starch series raw materiaI quaIity
齐麟 1陈仁萍 2连传宝 1尹建峰3
作者信息
- 1. 山东齐都药业有限公司，山东 临淄 255400
- 2. 山东省脑神经保护类药物重点实验室，山东 淄博 255400
- 3. 淄博市食品药品监督管理局，山东 淄博 255400
- 折叠
摘要
Abstract
This paper briefly described the classification of a series of hydroxyethyl starch APIs,clinical adverse reac-tions associated with key indicators of quality control and research situations according to the literature and reports.Moreo-ver,it emphasized the importance of unified quality standards of a series of hydroxyethyl starch APIs.关键词
羟乙基淀粉系列原料/不良反应/质量标准Key words
Hydroxyethyl starch APIs/Adverse reactions/Quality standards分类
化学化工引用本文复制引用
齐麟,陈仁萍,连传宝,尹建峰..羟乙基淀粉系列原料药质量控制研究[J].药学研究,2016,35(12):734-736,3.
